NIH-funded research NIH-funded research

Understanding how mTOR signaling affects post-traumatic osteoarthritis

Official title: Disentangling the role of mTOR in post-traumatic osteoarthritis

Funded at Wm S. Middleton Memorial Veterans Hosp · NIH-11051986 · Data updated 2026-11-12

This NIH grant investigates how two mTOR signaling pathways influence joint damage and pain after injury, with a focus on cartilage health and potential gender differences.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWm S. Middleton Memorial Veterans Hosp
NIH-funded
Lab location1 site (Madison, United States)
Project startJanuary 1, 2026
Project endDecember 31, 2029
Funding year2027
NIH project number1I01BX006404-01A1
Project IDNIH-11051986 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable for this basic science grant; however, future patients with joint injuries could benefit from therapies developed from these findings.

Less likely to help

Individuals seeking immediate clinical treatment today may not benefit directly.

What this research studies

Researchers will study how mTORC1 and mTORC2 contribute to osteoarthritis after joint injury, using animal models and various molecular approaches to separate the roles of each pathway. They will look at how blocking or altering mTOR signaling affects cartilage, joint tissues, and pain behaviors, aiming to pinpoint which branch could be targeted to prevent or lessen PTOA. The work will compare responses in males and females to see if sex influences the disease mechanism. The project will explore how current mTOR inhibitors interact with these pathways and what that means for potential therapies. Overall, the study seeks to clarify the biology so future treatments can be more precise and effective.”

Why it matters

Potential benefit: A clearer understanding of mTOR pathways could lead to targeted therapies to prevent or lessen PTOA and pain after joint injury.

How similar studies have gone: Prior studies show that mTOR signaling affects cartilage biology, but the specific roles of mTORC1 vs mTORC2 in PTOA are not yet resolved.

Where this research is happening

  • Wm S. Middleton Memorial Veterans Hosp
    Madison, United States
    Active

Researchers

  • Principal investigator: Konopka, Adam R — Wm S. Middleton Memorial Veterans Hosp
  • Study coordinator: Konopka, Adam R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.